Dr. Bidhu K Mohanti

Major Cancer Types Treated

• Head and Neck Cancers
• Gastrointestinal (GI) Cancers (including Gall Bladder, Esophageal)
• Hepato-biliary Cancers
• Pediatric Cancers
• Hematologic Malignancies (Lymphomas, Leukemias treated with Radiotherapy)
• Brain Tumors (Gliomas)
• Breast Cancer
• Lung Cancer
• Genitourinary Cancers

Sub-specialties

• Radiation Oncology
• Brachytherapy
• Palliative Care
• Cancer Survivorship
• Multi-Disciplinary Cancer Management

Advanced Procedures Performed

• Advanced Radiation Therapy Techniques (Implied, including likely IMRT, IGRT, VMAT based on experience level and institutions)
• Brachytherapy (Various sites)
• Palliative Radiotherapy protocols

Current & Past Hospital Affiliations

• Director, Bagchi Sri Shankara Cancer Centre & Research Institute (BSSCCRI), Bhubaneswar (Present)
• Director, KIMS Cancer Centre, Bhubaneswar (2020-2023)
• Consultant Radiation Oncologist, Manipal Hospitals, Dwarka, Delhi (2018-2020) – Involved in setting up services.
• Director and Head of Department – Radiation Oncology, Fortis Memorial Research Institute (FMRI), Gurgaon (2013-2018) – Set up oncology services post-AIIMS.
• Professor, Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi (1992-2013) – Took voluntary retirement.
• National Oncology Center, Royal Hospital, Muscat, Oman (2004-2006) – Established the Radiotherapy department.
• Faculty, Kidwai Memorial Institute of Oncology, Bangalore (1985 – 1992)

Academic & Research Roles

• Worked as Faculty and Consultant in Oncology for 38+ years (Kidwai, AIIMS).
• Professor of Radiation Oncology at AIIMS, New Delhi (until 2013).
• Extensive involvement in guiding teaching and research throughout his career.
• Principal Investigator / Co-Investigator on numerous research studies and clinical trials (as evidenced by publications).

Key Achievements & Contributions

• Pioneering role in establishing multiple comprehensive cancer care facilities (Muscat, Fortis Gurgaon, Manipal Dwarka, KIMS Bhubaneswar, BSSCCRI Bhubaneswar).
• Long and distinguished service as Professor at AIIMS, New Delhi, a premier medical institution.
• Significant contributions to national and international oncology through expert roles (IAEA, EC).
• Substantial research output with highly cited publications in leading medical journals.
• Expertise in Palliative Care, integrating it early into oncology practice.
• Leadership roles in national oncology associations (AROI, IAPC).

National & International Awards

• Dr. J M Pinto Best Paper Award, Association of Radiation Oncologists of India (AROI) (1989)
• Vocational Service Award, Delhi Rotary International (1993)

Recognitions & Honors

• Invited Presidential Session Lectures, German Society of Oncology (2009)
• Invited Presidential Session Lectures, Malaysian Oncological Society (2010)
• Expert, International Atomic Energy Agency (IAEA), Vienna
• Expert, European Commission (Framework-FP7- Cancer area), Brussels/Belgium (2010-2013)

Published Papers in Medical Journals
(Selected High-Impact Publications)

• Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol. (2010)
• Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys. (1996)
• Malignant peripheral nerve sheath tumors (MPNST)–clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol. (2006)
• Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects. J Cancer Res Ther. (2009)
• Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer. (2005)
• Lactobacillus brevis CD2 lozenges reduce radiation-and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer. (2012)
• Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol. (2004)
• Weight loss during radiotherapy for head and neck malignancies: what factors impact it?. Nutr Cancer. (2003)
• Ethics in palliative care. Indian J Palliat Care. (2009)

Books & Chapters Authored

• Authored a book titled, “FATHER a Policeman & SON an Oncologist” in 2023.

Consultation fees and overall treatment costs vary based on the specific services required, treatment modality, duration, and hospital policies. For detailed information on costs, contact Cancer Rounds.

• Language Support: English is proficiently spoken. Dr. Mohanti likely speaks Hindi and Odia. International patients can contact Cancer Rounds team to get treatment assistance in all languages.
• Visa & Travel Assistance: It is feasible to get international patient coordinator typically assists with visa invitation letters, travel arrangements, and accommodation guidance.

Patient Testimonials

“I highly recommend consulting Dr. Bidhu K Mohanti for cancer treatment.” – R. Sharma

“Being diagnosed with head and neck cancer was terrifying. Dr. Mohanti and his team were exceptional. He meticulously planned the radiation therapy, explained potential side effects, and proactively managed them.” – A. Kumar

“Dr. Mohanti is an expert in terms of advanced radiation therapies. I am very grateful to him for my successful treatment.” —- Rohan K.

Patient-Centred Care: Dr. Mohanti emphasizes a multi-disciplinary approach, ensuring patients benefit from the collective expertise of various specialists. He keeps a strong focus on palliative care principles, aiming to maintain the best possible quality of life alongside curative or life-prolonging treatment. Moreover, he believes in clear communication, educating patients and families about diagnosis, treatment options, and potential outcomes.

Technology & Innovation: Dr. Bidhu K Mohanti is actively involved in setting up state-of-the-art cancer centers, ensuring access to modern diagnostic and therapeutic technologies. He has a strong background in clinical research, contributing to and applying innovative treatment approaches (e.g., radiosensitizers like 2-DG).